Navigation Links
Accel-KKR Makes Growth Equity Investment in Zinc Ahead, Leading Provider of Marketing Compliance Solutions for the Life Sciences Industry
Date:6/21/2013

MENLO PARK, Calif. and OXFORD, England, June 21, 2013 /PRNewswire/ -- Accel-KKR, a technology-focused private equity investment firm, today announced it has made a growth equity investment in Zinc Ahead, the world's leading provider of marketing compliance solutions for the life sciences industry.  Terms of the investment were not disclosed. 

Zinc Ahead's flagship product, Zinc MAPS, is now used by more than 100 life sciences companies in over 160 countries worldwide, and is widely regarded as the gold standard in marketing compliance solutions in the life sciences industry.  The company was founded by James Brown and Zoe Cottrell in 2001.

Accel-KKR Managing Director Greg Williams commented about the investment: "We are excited to partner with James Brown and Zoe Cottrell and the Zinc Ahead team as they continue to execute the growth plan that has established the company as a market leader in life sciences marketing compliance solutions.  This investment fits very well with our focus on investing in and supporting market leading software and technology-enabled service businesses."

James Brown, CEO and co-founder of Zinc Ahead, said: "Over the past dozen years, our company has generated strong growth as we have established Zinc MAPS as the gold standard marketing compliance solution designed specifically for the life sciences industry.  The investment from Accel-KKR will enable Zinc to continue its growth on a global scale, especially in North America.  Accel-KKR team has deep knowledge of software and extensive experience investing alongside founder-led management teams, and they will be a tremendous partner as we grow."

Accel-KKR Managing Director '/>"/>

SOURCE Accel-KKR
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. As Released on 30 December, 2011: Novogen Modifies ADR Program and Makes Further Investment Into Marshall Edwards
2. The Lancet Makes Research More Accessible for Healthcare Professionals With New App for iPad
3. GeNO LLC Makes Significant Additions to Management Team to Increase Capability and Talent
4. Oracle chairman Jeff Henley makes $50 million gift to UC Santa Barbara
5. Foundation Venture Capital Group Makes Eighth Start-Up Investment
6. Infectious Disease Prevalence and New Strains Appearing Each Year Makes a Watertight Case for Clinical Laboratory Testing, Finds Frost & Sullivan
7. Chemical makes blind mice see; compound holds promise for treating humans
8. Mass spec makes the clinical grade
9. Metabolic engineer synthesizes key breast milk ingredient, makes research possible
10. Lava dots: Rice makes hollow, soft-shelled quantum dots
11. Alpha Source, Inc. Makes Third Straight Inc. 5000 List with Three-Year Sales Growth of 53%
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... Freeslate, Inc ., the leading provider ... Limited, one of India’s top five pharmaceutical companies, has ... for high throughput solid form screening. , ... wide range of quality, affordable generic and branded formulations ...
(Date:1/14/2014)... 2014 Histogen, Inc., a regenerative medicine ... grown under simulated embryonic conditions, today announced that they ... Medical, Inc. for physician-dispensed aesthetic products containing Histogen’s proprietary ... agreement is an amendment to the existing license between ...
(Date:1/14/2014)... Md. , Jan. 14, 2014  Organovo announced today ... the National Institutes of Health (NIH) to help scientists ... treatments to patients on a faster timeline. Organovo is ... (NCATS) and the National Eye Institute (NEI) to develop ...
(Date:1/14/2014)... Ontario , Jan. 14, 2014   Kinaxis ®, provider ... SCM ) and sales and operations planning ( S&OP ) ... Biomanufacturing Summit , which will be held at the ... the conference, join Kinaxis customer Elisabeth Kaszas , Director ...
Breaking Biology Technology:Lupin Selects Freeslate’s CM Protégé PharmD System to Accelerate Polymorph Screening for Drug Development 2Lupin Selects Freeslate’s CM Protégé PharmD System to Accelerate Polymorph Screening for Drug Development 3Histogen and Suneva Medical Expand License for Cell Conditioned Media-based Aesthetic Products Internationally 2Histogen and Suneva Medical Expand License for Cell Conditioned Media-based Aesthetic Products Internationally 3Organovo Announces Collaboration with National Institutes of Health 2Organovo Announces Collaboration with National Institutes of Health 3Event Alert: Kinaxis Customer to Present at the Biomanufacturing Summit "Supply Chain: Improving Network Effectiveness" 2
... Research Institute (IDRI) announces today the appointment of H. ... new member of the IDRI board of directors.  Parker ... having served as President and CEO of Targeted Genetics ... Corp. "I look forward to working with ...
... FORT WORTH, Texas, Feb. 15, 2011 The Center ... Center recently received a three-year $3.5 million grant ... leader in forensic DNA testing systems, to train researchers ...  This first of its kind accelerated academic certification program ...
... 15, 2011 Neuralstem, Inc. (NYSE Amex: ... I. Westreich to its Board of Directors. With his ... majority of independent directors. (Logo: http://photos.prnewswire.com/prnh/20061221/DCTH007LOGO) ... of Directors and the Company,s Chief Science Officer, welcomed ...
Cached Biology Technology:IDRI Announces Appointment of H. Stewart Parker as Chief Executive Officer 2$3.5 Million Life Technologies Grant Will Help Train, Certify Forensic Scientists at UNT Health Science Center 2$3.5 Million Life Technologies Grant Will Help Train, Certify Forensic Scientists at UNT Health Science Center 3$3.5 Million Life Technologies Grant Will Help Train, Certify Forensic Scientists at UNT Health Science Center 4Former Capital One Director and Business Leader Stanley I. Westreich Joins Neuralstem's Board 2Former Capital One Director and Business Leader Stanley I. Westreich Joins Neuralstem's Board 3
(Date:4/17/2014)... to treat tuberculosis could be the basis for a ... fungal infections and parasites, yet evade resistance, according to ... , Led by U. of I. chemistry professor Eric ... SQ109 attacks the tuberculosis bacterium, how the drug can ... malaria and how targeting multiple pathways reduces the ...
(Date:4/17/2014)... a word for chili peppers. Information about archaeological remains ... study of the appearance of words for chili peppers ... were domesticated and highlight the value of multi-proxy data ... al.) of nine papers presented in a special feature ... of Sciences on plant and animal domestication edited ...
(Date:4/17/2014)... NJ. April 16, 2014. Kessler Foundation has been ... million from the Department of Defense Spinal Cord ... principal investigator for the randomized, double-blinded, controlled, multi-site ... bone and muscle strength after spinal cord injury. ... & Engineering Research at Kessler Foundation. Two additional ...
Breaking Biology News(10 mins):Multitarget TB drug could treat other diseases, evade resistance 2Chickens to chili peppers 2Chickens to chili peppers 3Kessler Foundation awarded Department of Defense grant for spinal cord injury research 2
... Calif.) Calling the results "extremely surprising," researchers from ... University report that methane gas concentrations in the Gulf ... months after a massive release occurred following the Deepwater ... study, led by oceanographers John Kessler of Texas A&M ...
... team took a significant step forward in understanding ... pollutants and some other gases, except carbon dioxide. ... with some studies suggesting the self-cleaning power of ... changes, while others suggest greater stability. And what ...
... scientists "build" new biological systems, Princeton University scientists have ... the growth of living cells. The team of ... and the scientists showed that they can produce substances ... proteins produced by nature,s own toolkit. "What ...
Cached Biology News:UCSB, Texas A&M scientists find methane gas concentrations have returned to near-normal levels 2NOAA-led team measures atmosphere's self-cleaning capacity 2NOAA-led team measures atmosphere's self-cleaning capacity 3Princeton scientists construct synthetic proteins that sustain life 2Princeton scientists construct synthetic proteins that sustain life 3
... Cell Receptor-P1, clone 1C10 ... Hybridoma produced by the fusion ... immunized (BALB/c X C57BL/6)F1 (CbyB6F1) ... mouse myeloma cellline. ...
... Mouse monoclonal [YPF19] to Yersinia pestis ... detect Yersinia pestis . ... Yersinia pestis vaccine strain ... antibody recognises Y.pestis F1 capsular antigen. ...
Rabbit polyclonal to ZFP200 ( Abpromise for all tested applications). Antigen: Synthetic peptide: CGKSFNHKTNLNKHER (Human) Entrez Gene ID: 7752 Swiss Protein ID: P98182...
Anti-human C3a/C3a des-Arg (neo-epitope), Clone 2991, Monoclonal Antibody...
Biology Products: